These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29111366)

  • 1. Corrigendum to "Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors" [Bioorg. Med. Chem. 25 (2017) 5077-5083].
    Innocenti R; Lenci E; Menchi G; Pupi A; Trabocchi A
    Bioorg Med Chem; 2017 Dec; 25(24):6724-6725. PubMed ID: 29111366
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors.
    Innocenti R; Lenci E; Menchi G; Pupi A; Trabocchi A
    Bioorg Med Chem; 2017 Oct; 25(19):5077-5083. PubMed ID: 28359674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to 'Design, synthesis and in vitro study of densely functionalized oxindoles as potent α-glucosidase inhibitors' [Bioorg. Med. Chem. 26(18) (2018) 4996-5005].
    Luthra T; Naga Lalitha K; Agarwal R; Uma A; Sen S
    Bioorg Med Chem; 2018 Dec; 26(23-24):6153. PubMed ID: 30470596
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855].
    Bioorg Med Chem; 2015 Aug; 23(15):5078. PubMed ID: 26425745
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].
    Maryanoff BE
    Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Jan; 28(2):115255. PubMed ID: 31862309
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Oct; 28(19):115687. PubMed ID: 32826133
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors" [Bioorg. Med. Chem. 27 (2019) 115147].
    Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
    Bioorg Med Chem; 2020 Feb; 28(4):115293. PubMed ID: 31892438
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR" [Bioorg. Med. Chem. 23, 2015, 2767-2780].
    Basu D; Richters A; Rauh D
    Bioorg Med Chem; 2015 Aug; 23(15):5075. PubMed ID: 32689707
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors" [Bioorg. Med. Chem. 26 (12) (2018) 3696-3706].
    Ullah Mughal E; Javid A; Sadiq A; Murtaza S; Naveed Zafar M; Ahmad Khan B; Hussain Sumrra S; Nawaz Tahir M; Kanwal ; Mohammed Khan K
    Bioorg Med Chem; 2018 Jul; 26(13):3860. PubMed ID: 29983283
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].
    Li P; Cai S; Zhao T; Xu L; Guan D; Li J; Zhou J; Zhang H
    Bioorg Med Chem Lett; 2022 Jan; 56():128502. PubMed ID: 34906405
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to 'Design and synthesis of Coenzyme A analogues as Aurora kinase A inhibitors: An exploration of the roles of the pyrophosphate and pantetheine moieties'. [Bioorg. Med. Chem. 28 (2020) 115740].
    Bellany F; Tsuchiya Y; Tran TM; Edith Chan AW; Allan H; Gout I; Tabor AB
    Bioorg Med Chem; 2021 Jun; 40():116106. PubMed ID: 33985868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors" [Bioorg. Med. Chem. 40 (2021) 116186].
    Bu H; Yuan X; Wu H; Zhou J; Zhang H
    Bioorg Med Chem; 2022 Jan; 54():116578. PubMed ID: 34920926
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419].
    Kumar A; Tripathi VD; Kumar P; Gupta LP; Akanksha ; Trivedi R; Bid H; Nayak VL; Siddiqui JA; Chakravarti B; Saxena R; Dwivedi A; Siddiquee MI; Siddiqui U; Konwar R; Chattopadhyay N
    Bioorg Med Chem; 2019 Sep; 27(17):3960-3961. PubMed ID: 31345744
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
    Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations" [Bioorg. Med. Chem. 25 (2017) 6273-6285].
    Singh M; Kaur M; Singh N; Silakari O
    Bioorg Med Chem; 2018 Aug; 26(14):4360-4361. PubMed ID: 29941194
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity" [Bioorg. Med. Chem. 25 (2017) 1524-1532].
    Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2017 Apr; 25(8):2530. PubMed ID: 28285926
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives" [Bioorg. Med. Chem. 15 (2007) 2434-2440].
    Metwally K; Aly O; Aly E; Banerjee A; Ravindra R; Bane S
    Bioorg Med Chem; 2017 May; 25(9):2679. PubMed ID: 28341404
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.